AT EVERY STEP OF THE RESEARCH PROCESS FROM THE LAB TO THE CLINIC, WE ARE PURSUING INNOVATIVE WAYS TO PREVENT AND CONTROL CANCER.
Bing Ren of Ludwig San Diego has been tapped to play a key role in a major initiative launched by the US National Institutes of Health that will transform how we read and interpret the genome.
This treatment proved highly effective in clinical trials led by Ludwig MSK’s Jedd Wolchok and Ludwig Harvard’s Stephen Hodi.
This report features success stories from across the global Ludwig community about the innovative ways we are tackling cancer from basic research to translational medicine. We hope you enjoy it!